Publications by the researcher in collaboration with Estrella Martín Mazuelos (22)

2022

  1. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

2012

  1. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187

2011

  1. Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients

    BMC Infectious Diseases, Vol. 11

  2. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  3. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596

  4. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica

2010

  1. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: A comparison with the M27-A3 reference method

    Medical Mycology, Vol. 48, Núm. 5, pp. 710-719

2009

  1. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients

    Clinical Microbiology and Infection, Vol. 15, Núm. 6, pp. 592-595

2007

  1. Update on invasive fungal infections: the last two years

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 19-27

2004

  1. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts

    Revista Iberoamericana de Micologia, Vol. 21, Núm. 2, pp. 63-69

2002

  1. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species

    Chemotherapy, Vol. 48, Núm. 1, pp. 21-25

2001

  1. Estudio epidemiológico de la criptococosis en España: Primeros resultados

    Revista Iberoamericana de Micologia, Vol. 18, Núm. 3, pp. 99-104

  2. Evaluación micológica de un nuevo medio de cultivo cromógeno (Candida ID®) para el aislamiento e identificación presuntiva de Candida albicans y otras levaduras de interés médico

    Revista Iberoamericana de Micologia, Vol. 18, Núm. 1, pp. 23-28

2000

  1. Actividad in vitro de una formulacion liposomica de nistatina (Nyotran®) frente a Cryptococcus neoformans

    Revista Iberoamericana de Micologia, Vol. 17, Núm. 3, pp. 90-92

  2. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole

    Chemotherapy, Vol. 46, Núm. 4, pp. 235-244

  3. In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 19, Núm. 8, pp. 645-648

  4. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents

    Chemotherapy, Vol. 46, Núm. 6, pp. 395-401

  5. Sensibilidad a fluconazol e itraconazol en aislamientos de Candida spp. procedentes de pacientes VIH positivos y VIH negativos

    Revista Espanola de Quimioterapia, Vol. 13, Núm. 1, pp. 60-63

1999

  1. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.

    Journal of Antimicrobial Chemotherapy, Vol. 43, Núm. 4, pp. 477-481

  2. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing

    Revista Iberoamericana de Micologia, Vol. 16, Núm. 2, pp. 92-96